SMI
12.644,49
PKT
-57,59
PKT
-0,45
%
Werbung
Analysen zu SMI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 20.01.05 | Logitech Buy | Sarasin Research | |
| 20.01.05 | Holcim Neutral | Sarasin Research | |
| 20.01.05 | Novartis Akkumulieren | Independent Research | |
| 20.01.05 | Logitech Buy | Sarasin Research | |
| 21.01.05 | Holcim Accumulate | Helvea | |
| 20.01.05 | Novartis Neutral | Sarasin Research | |
| 21.01.05 | Logitech Accumulate | Helvea | |
| 21.01.05 | Novartis Buy | Helvea | |
| 20.01.05 | Swiss Life Buy | M.M. Warburg | |
| 20.01.05 | UBS Buy | Sarasin Research | |
| 20.01.05 | Richemont Outperform | Goldman Sachs | |
| 19.01.05 | Novartis Equal-weight | Morgan Stanley | |
| 19.01.05 | Zurich Insurance Overweight | Lehman Brothers | |
| 19.01.05 | Nestlé In-Line | Goldman Sachs | |
| 21.01.05 | Novartis Kaufen | Helaba Trust | |
| 21.01.05 | Nestlé Kaufen | Helaba Trust | |
| 19.01.05 | Givaudan Neutral | Sarasin Research | |
| 20.01.05 | Logitech In-Line | Goldman Sachs | |
| 19.01.05 | Holcim In-Line | Goldman Sachs | |
| 18.01.05 | Novartis Buy | AG Edwards | |
| 18.01.05 | Novartis Outperform | Bear Stearns | |
| 18.01.05 | Novartis Buy | Merrill Lynch | |
| 18.01.05 | Richemont Overweight | Lehman Brothers | |
| 18.01.05 | Novartis Akkumulieren | Independent Research | |
| 18.01.05 | Roche Buy | Merrill Lynch | |
| 18.01.05 | Novartis Buy | Sarasin Research | |
| 20.01.05 | Zurich Insurance Outperform | Goldman Sachs | |
| 18.01.05 | Novartis Buy | Merrill Lynch | |
| 24.01.05 | Zurich Insurance Neutral | Sal. Oppenheim | |
| 24.01.05 | Swiss Life Neutral | Sal. Oppenheim | |
| 18.01.05 | Lonza Buy | Helvea | |
| 18.01.05 | Nestlé Buy | Helvea | |
| 17.01.05 | Logitech Buy | Sarasin Research | |
| 17.01.05 | Holcim Halten | Helaba Trust | |
| 17.01.05 | Lonza Reduce | Sarasin Research | |
| 18.01.05 | Geberit Market Outperform | Vontobel | |
| 17.01.05 | Richemont Buy | Sarasin Research | |
| 18.01.05 | UBS Buy | Sarasin Research | |
| 17.01.05 | Swiss Life Outperform | HypoVereinsbank | |
| 17.01.05 | Novartis Sector Outperform | Vontobel |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.